Does ERBITUX SOLN FOR INF /ML Cause Interstitial lung disease? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Interstitial lung disease have been filed in association with ERBITUX SOLN FOR INF /ML. This represents 10.9% of all adverse event reports for ERBITUX SOLN FOR INF /ML.
6
Reports of Interstitial lung disease with ERBITUX SOLN FOR INF /ML
10.9%
of all ERBITUX SOLN FOR INF /ML reports
6
Deaths
1
Hospitalizations
How Dangerous Is Interstitial lung disease From ERBITUX SOLN FOR INF /ML?
Of the 6 reports, 6 (100.0%) resulted in death, 1 (16.7%) required hospitalization, and 2 (33.3%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ERBITUX SOLN FOR INF /ML. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does ERBITUX SOLN FOR INF /ML Cause?
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)